Growth expansion Novogene America is expanding its footprint with a new Beaverton, Oregon facility and ongoing multi-omics service launches, indicating growing capacity and geographic coverage that create cross-sell opportunities for genomics services and associated bioinformatics solutions.

Advanced omics Recent launches with DIA quantitative proteomics and untargeted metabolomics, plus Spatial Transcriptomics capabilities, position Novogene as a one-stop provider for large-scale omics workflows, enabling targeted upsell to customers needing end-to-end multi-omics data generation and analysis.

Market leadership With the largest sequencing capacity worldwide, substantial patent portfolio, and collaborations across the Americas, Novogene can leverage credibility to pursue enterprise customers seeking high-throughput, quality-controlled sequencing services and scalable bioinformatics support.

Strategic partnerships Global collaborations and presence in UC Davis and Europe create co-selling and academic-industry partnerships, offering sales opportunities through joint projects, sponsored research programs, and long-term service contracts with research institutions.

Data and workflow integration Strong emphasis on NGS and bioinformatics expertise, complemented by diverse tech stack and first-tier publications, suggests potential for selling integrated data management, analytics platforms, and custom pipeline development for clients needing seamless data-to-insight workflows.